M, S., M, F., K, K., & A, M. (2024). Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines. Cancer investigation, 42(4), 319. https://doi.org/10.1080/07357907.2024.2345183
Chicago Style (17th ed.) CitationM, Soleiman, Fathi-Roudsari M, Khajeh K, and Maghsoudi A. "Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect Against Glioblastoma Multiform Cancer Cell Lines." Cancer Investigation 42, no. 4 (2024): 319. https://doi.org/10.1080/07357907.2024.2345183.
MLA (9th ed.) CitationM, Soleiman, et al. "Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect Against Glioblastoma Multiform Cancer Cell Lines." Cancer Investigation, vol. 42, no. 4, 2024, p. 319, https://doi.org/10.1080/07357907.2024.2345183.